Get the Stockscreener App
584.91
0.78%
4.54
Pre-market:
578.75
-6.16
-1.05%
Medpace Holdings Inc stock is traded at $584.91, with a volume of 220.16K.
It is up +0.78% in the last 24 hours and up +13.76% over the past month.
Medpace is a late-stage contract research organization that provides full-service drug-development and clinical trial services to small and midsize biotechnology, pharmaceutical, and medical device firms. It also offers ancillary services, including bioanalytical laboratory services and imaging capabilities. The company was founded over 30 years ago and has more than 5,400 employees across 40 countries. Medpace is headquartered in Cincinnati, Ohio, and its operations are primarily based in the US, with additional presence in Europe, Asia, South America, Africa, and Australia. Cinven, a global private equity firm, acquired Medpace for $915 million in 2014 and exited its investment in 2018.
See More
Previous Close:
$580.37
Open:
$580.37
24h Volume:
220.16K
Relative Volume:
0.65
Market Cap:
$16.43B
Revenue:
$2.23B
Net Income/Loss:
$418.30M
P/E Ratio:
43.50
EPS:
13.4469
Net Cash Flow:
$579.82M
1W Performance:
-3.35%
1M Performance:
+13.76%
6M Performance:
+89.67%
1Y Performance:
+86.15%
1-Day Range:
$572.50
$588.53
1-Week Range:
$571.03
$614.04
52-Week Range:
$250.05
$625.00
Medpace Holdings Inc Stock (MEDP) Company Profile
Name
Medpace Holdings Inc
Sector
Industry
Phone
(513) 579-9911
Address
5375 MEDPACE WAY, CINCINNATI, OH
Compare MEDP with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
MEDP
Medpace Holdings Inc
|
584.91 | 16.35B | 2.23B | 418.30M | 579.82M | 13.45 |
|
TMO
Thermo Fisher Scientific Inc
|
567.39 | 210.04B | 43.74B | 6.59B | 6.11B | 17.30 |
|
DHR
Danaher Corp
|
215.38 | 151.90B | 24.27B | 3.50B | 5.02B | 4.8589 |
|
IDXX
Idexx Laboratories Inc
|
629.51 | 50.29B | 4.04B | 985.66M | 774.34M | 12.01 |
|
A
Agilent Technologies Inc
|
146.36 | 40.64B | 6.79B | 1.22B | 1.09B | 4.2644 |
|
IQV
Iqvia Holdings Inc
|
216.46 | 36.86B | 15.90B | 1.28B | 2.21B | 7.2842 |
Medpace Holdings Inc Stock (MEDP) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Oct-02-25 | Downgrade | Barclays | Equal Weight → Underweight |
| Sep-03-25 | Downgrade | Rothschild & Co Redburn | Buy → Neutral |
| Jul-29-25 | Downgrade | UBS | Neutral → Sell |
| Jul-23-25 | Downgrade | TD Cowen | Hold → Sell |
| Jun-24-25 | Initiated | Barclays | Equal Weight |
| Apr-22-25 | Downgrade | William Blair | Outperform → Mkt Perform |
| Apr-14-25 | Downgrade | TD Cowen | Buy → Hold |
| Mar-24-25 | Initiated | Leerink Partners | Market Perform |
| Oct-23-24 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Oct-14-24 | Initiated | Redburn Atlantic | Buy |
| Sep-27-24 | Downgrade | UBS | Buy → Neutral |
| Sep-25-24 | Downgrade | Jefferies | Buy → Hold |
| Aug-01-24 | Initiated | Truist | Hold |
| May-29-24 | Initiated | TD Cowen | Buy |
| May-28-24 | Initiated | Mizuho | Buy |
| Apr-23-24 | Upgrade | Jefferies | Hold → Buy |
| Mar-18-24 | Initiated | Deutsche Bank | Hold |
| Feb-15-24 | Upgrade | UBS | Neutral → Buy |
| Oct-24-23 | Upgrade | Robert W. Baird | Neutral → Outperform |
| May-08-23 | Upgrade | Guggenheim | Neutral → Buy |
| Oct-27-22 | Upgrade | UBS | Sell → Neutral |
| Sep-07-22 | Initiated | UBS | Sell |
| May-24-22 | Initiated | Guggenheim | Neutral |
| Aug-05-21 | Resumed | Credit Suisse | Outperform |
| Oct-02-20 | Upgrade | Truist | Hold → Buy |
| Jun-08-20 | Upgrade | Robert W. Baird | Underperform → Neutral |
| May-13-20 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| Apr-30-20 | Upgrade | SunTrust | Sell → Hold |
| Apr-20-20 | Downgrade | Robert W. Baird | Neutral → Underperform |
| Mar-17-20 | Downgrade | SunTrust | Hold → Sell |
| Jan-27-20 | Downgrade | SunTrust | Buy → Hold |
| Oct-31-18 | Upgrade | SunTrust | Hold → Buy |
| Sep-17-18 | Initiated | SunTrust | Hold |
| Jul-31-18 | Upgrade | William Blair | Mkt Perform → Outperform |
| Nov-01-17 | Downgrade | William Blair | Outperform → Mkt Perform |
| Sep-29-17 | Initiated | Raymond James | Mkt Perform |
| Jul-10-17 | Downgrade | KeyBanc Capital Mkts | Overweight → Sector Weight |
View All
Medpace Holdings Inc Stock (MEDP) Latest News
Envestnet Asset Management Inc. Has $32.30 Million Stock Position in Medpace Holdings, Inc. $MEDP - MarketBeat
Will Medpace Holdings Inc. (01P) stock outperform Dow JonesFed Meeting & Intraday High Probability Alerts - newser.com
How strong is Medpace Holdings Inc. (01P) stock earnings growthChart Signals & Community Trade Idea Sharing Platform - newser.com
Using RSI to spot recovery in Medpace Holdings Inc.IPO Watch & Stepwise Entry and Exit Trade Signals - newser.com
Is Medpace Holdings Inc. stock bottoming outMarket Volume Report & Free High Accuracy Swing Entry Alerts - newser.com
Combining machine learning predictions for Medpace Holdings Inc.Earnings Recap Report & Daily Oversold Stock Bounce Ideas - newser.com
Why Medpace Holdings Inc. (01P) stock signals breakout potential2025 Top Gainers & Technical Confirmation Trade Alerts - newser.com
Medpace shares plunge 8% as 2025 guidance disappoints - MSN
Should I hold or sell Medpace Holdings Inc. stock in 2025July 2025 Earnings & Reliable Volume Spike Alerts - newser.com
Is Medpace Holdings Inc. meeting your algorithmic filter criteria2025 Key Highlights & Capital Protection Trading Alerts - newser.com
Medpace Holdings (MEDP) Generated Strong Results in Q3 - MSN
This Insider Has Just Sold Shares In Medpace Holdings - simplywall.st
Retirement Systems of Alabama Reduces Stake in Medpace Holdings, Inc. $MEDP - MarketBeat
Combining price and volume data for Medpace Holdings Inc.2025 EndofYear Setup & Daily Risk Controlled Trade Plans - newser.com
How institutional buying supports Medpace Holdings Inc. stock2025 Fundamental Recap & Weekly High Return Forecasts - newser.com
What analysts say about Medpace Holdings Inc stockCup and Handle Formations & Explosive Profit Potential - earlytimes.in
Weiss Ratings Reiterates Buy (B) Rating for Medpace (NASDAQ:MEDP) - MarketBeat
How Medpace Holdings Inc. (01P) stock gains from tech spendingEarnings Recap Report & Advanced Swing Trade Entry Alerts - newser.com
How to forecast Medpace Holdings Inc. trends using time seriesWeekly Stock Report & Free High Return Stock Watch Alerts - newser.com
Volume spikes in Medpace Holdings Inc. stock – what they meanTrend Reversal & Verified Trade Idea Suggestions - newser.com
Medpace Holdings, Inc. $MEDP Stock Holdings Increased by Teacher Retirement System of Texas - MarketBeat
Medpace and Radiopharm Theranostics Advance Brain Metastases Imaging Study - MSN
Will Medpace Holdings Inc. stock return to pre crisis levelsJuly 2025 Macro Moves & High Conviction Buy Zone Alerts - newser.com
Will Medpace Holdings Inc. (01P) stock sustain bullish trend into 2025Rate Cut & Fast Entry High Yield Tips - newser.com
GWN Securities Inc. Takes $243,000 Position in Medpace Holdings, Inc. $MEDP - MarketBeat
How Medpace Holdings Inc. stock performs in high volatility markets2025 Growth vs Value & Free Community Supported Trade Ideas - newser.com
Medpace Holdings, Inc. (MEDP) Analyst Insights, Price Targets & Recommendations - Yahoo! Finance Canada
Medpace Holdings, Inc. (MEDP) Analyst insights, Price targets and Recommendations - Yahoo! Finance UK
Medpace (NASDAQ:MEDP) General Counsel Sells 15,230 Shares - MarketBeat
Insider Selling: Medpace (NASDAQ:MEDP) President Sells 19,460 Shares of Stock - MarketBeat
Jesse Geiger Sells 3,568 Shares of Medpace (NASDAQ:MEDP) Stock - MarketBeat
Insider Selling: Medpace (NASDAQ:MEDP) VP Sells 2,000 Shares of Stock - MarketBeat
Best Momentum Stock to Buy for Oct. 28th - MSN
MEDP (Medpace Holdings) Cyclically Adjusted Book per Share : $20.31 (As of Sep. 2025) - GuruFocus
Medpace and Telix Collaborate on Promising Phase 3 Study for Advanced Kidney Cancer - MSN
Medpace (NASDAQ:MEDP) Stock Rating Upgraded by Zacks Research - MarketBeat
Medpace Holdings Inc: A New Frontier in Carotid Artery Treatment - MSN
Medpace Holdings, Inc. (MEDP) Stock Forecasts - Yahoo Finance
Medpace and Edgewise Therapeutics Advance Becker Muscular Dystrophy Study - MSN
Medpace Holdings Inc Stock (MEDP) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.11%
0.00%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):